Myocyte-specific enhancer factor 2A

From WikiMD's WELLNESSPEDIA

Myocyte-specific enhancer factor 2A (MEF2A) is a protein that in humans is encoded by the MEF2A gene. This protein is a member of the myocyte enhancer factor 2 (MEF2) family of transcription factors, which play crucial roles in the regulation of gene expression in muscle cells and other tissues.

Structure[edit]

MEF2A contains a highly conserved MADS-box domain and an adjacent MEF2 domain, which are essential for DNA binding and dimerization. The protein also has regions that mediate interactions with other transcription factors and coactivators, facilitating the regulation of target gene expression.

Function[edit]

MEF2A is involved in the regulation of muscle cell differentiation and development. It binds to specific DNA sequences in the promoter regions of target genes, activating their transcription. MEF2A is also implicated in various cellular processes, including cell cycle regulation, apoptosis, and signal transduction pathways.

Role in Disease[edit]

Mutations in the MEF2A gene have been associated with coronary artery disease (CAD) and myocardial infarction. Research suggests that these mutations may disrupt the normal function of MEF2A, leading to impaired cardiovascular health.

Interactions[edit]

MEF2A interacts with several other proteins, including histone deacetylases (HDACs), coactivators, and other transcription factors. These interactions are critical for the modulation of MEF2A activity and the fine-tuning of gene expression.

Related Proteins[edit]

Other members of the MEF2 family include MEF2B, MEF2C, and MEF2D. These proteins share similar structural features and functions but have distinct roles in different tissues and developmental stages.

Research and Applications[edit]

MEF2A is a subject of ongoing research, particularly in the context of cardiovascular disease and muscle biology. Understanding the mechanisms by which MEF2A regulates gene expression may lead to new therapeutic strategies for treating related conditions.

See Also[edit]

References[edit]


External Links[edit]

Template:Transcription-factor-stub


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=Myocyte-specific_enhancer_factor_2A&oldid=6513965"